Navigation Links
2 Mutations Were Critical to Spread of 1918 Flu
Date:2/19/2008

The findings could aid investigation of current bird flu, experts say

TUESDAY, Feb. 19 (HealthDay News) -- New research on the spread of the 1918 influenza virus, which killed more than 50 million people worldwide, may aid research into today's potentially dangerous bird flu strain, scientists say.

MIT researchers found that the 1918 avian flu virus strain developed two mutations in a surface molecule called hemagglutinin (HA), which allowed it to bind tightly to receptors in the human upper respiratory tract. This ability to "lock in" was critical for viral transmission in humans, according to the findings, published in Feb. 18 issue of the Proceedings of the National Academy of Sciences.

"Two mutations dramatically change the HA binding affinity to receptors found in the human upper airways," said the paper's senior author Ram Sasisekharan, the Underwood Prescott Professor of Biological Engineering and Health Sciences and Technology, in a prepared statement.

Sasisekharan and colleagues previously reported in January's Nature Biotechnology that flu viruses can only bind to human respiratory cells if they match the shape of sugar (or glycan) receptors found on those cells. The receptors, known as alpha 2-6 in humans, come in two shapes -- one resembling a cone; the other an open umbrella.

In the new study, the team discovered that for avian flu viruses to transmit from birds to humans, they must gain the ability to bind tightly or with a high affinity to the umbrella-shaped receptors.

"The affinity between the influenza virus HA and the glycan receptors appears to be a critical determinant for viral transmission," Sasisekharan said.

The researchers compared the influenza virus that caused the 1918 pandemic with two similar strains (called NY18 and AV18) that differ from it by only one or two amino acids.

Using ferrets (which are susceptible to human flu strains), researchers had earlier found that the pandemic virus transmitted efficiently between ferrets, while the NY18 strain proved only slightly infectious and AV18 not at all infectious.

While slightly infectious NY18 binded to the umbrella-shaped glycan receptors, it did not do it as well as the highly infectious pandemic strain did. The non-infectious AV18 strain had no affinity for the receptors.

Another strain, TX18, proved much more infectious than NY18, and it bonded with high affinity to the umbrella-shaped receptors.

Researchers from the Centers for Disease Control and Prevention reported on the infectiousness of these strains last year, but the MIT study is the first to explain the biochemical reason causing these differences.

More information

The U.S. Centers for Disease Control and Prevention has more about influenza.



-- Kevin McKeever



SOURCE: Massachusetts Institute of Technology, news release, Feb. 18, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Gene Mutations May Cause Rare Neonatal Diabetes
2. Ashkenazi ovarian cancer patients with BRCA mutations live longer than those with normal gene
3. BRCA Mutations Dont Raise Breast Cancer Risk Equally
4. Genetic Mutations Boost Prostate Cancer Risk
5. Scientists explore factors contributing to DNA mutations
6. Benefit of cancer prevention surgery differs between women with BRCA1 and BRCA2 mutations
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Middle School Marks Most Critical Time to Start Ongoing Conversations About Drug and Alcohol Use With Kids
9. Oncologists are critical in managing psychiatric disorders in patients with advanced cancer
10. Consumer Specialty Products Association Highly Critical of NRDC Study on Home Air Fresheners
11. Critical blood shortages eased by new technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... ... TherapySites, the leading website and online marketing ... Association. This new relationship allows TherapySites to continue to extend their online ... and promotional offers. , "TCA is extremely excited about this new partnership, as ...
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to ... of individuals in the United States and Canada wear eyeglasses. Once considered to be ... vision and make a fashion statement. Even celebrities use glasses as a way of ...
(Date:6/26/2016)... ... ... Pixel Film Studios Released ProSlice Levels, a Media Slicing Effect Plugin ... whole new perspective by using the title layers in ProSlice Levels to split-up ... Levels contains over 30 Different presets to choose from. FCPX users can ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are ... with endometriosis. These women need a treatment plan to not only alleviate symptoms ... can help for preservation of fertility and ultimately achieving a pregnancy. The specialists ...
(Date:6/25/2016)... ... ... temporary closing of Bruton Memorial Library on June 21 due to a possible lice infestation, ... aspect of head lice: the parasite’s ability to live away from a human host, and ... necessary one in the event that lice have simply gotten out of control. , As ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... , June 23, 2016 Bracket , ... launch its next generation clinical outcomes platform, Bracket eCOA (SM) ... held on June 26 – 30, 2016 in ... first electronic Clinical Outcome Assessment product of its kind to ... #715. Bracket eCOA 6.0 is a flexible platform ...
(Date:6/23/2016)... LONDON , June 23, 2016 ... environments  Oticon , industry leaders in ... the launch of Oticon Opn ™, the world,s ... world of possibilities for IoT devices.      ... Opn, Oticon introduces a number of ,world firsts,: ...
Breaking Medicine Technology: